HomeInsightsMarket Capitalization

Market Capitalization of Fredun Pharmaceuticals Ltd

Market Capitalization of Fredun Pharmaceuticals Ltd

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Dec 4, 2024)

stocks purchased

3.5 K

Stocks Traded

(Dec 4, 2024)

Last Updated on: Dec 04, 2024

Image

Fredun Pharmaceuticals Ltd

NSE: FREDUNPHARMA

Market Cap

₹ 366.58 crore

Last updated on: Dec 04, 2024

Key Highlights

  • The Market Cap of Fredun Pharmaceuticals Ltd is ₹ 366.58 crore as of 04 Dec 24 .
  • The Market Cap of Fredun Pharmaceuticals Ltd changed from ₹ 168.8 crore on March 2019 to ₹ 337.07 crore on March 2024 . This represents a CAGR of 12.22% over 6 years.
  • The Latest Trading Price of Fredun Pharmaceuticals Ltd is ₹ 780.1 as of 04 Dec 15:30 .
  • The dividend payouts of Fredun Pharmaceuticals Ltd changed from ₹ 0.6 to ₹ 0.7 over 6 quarters. This represents a CAGR of 10.82% .

Historical Market Cap of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Fredun Pharmaceuticals Ltd

No data available

Image

Fredun Pharmaceuticals Ltd

NSE: FREDUNPHARMA

Share Price

₹ 780.1

-8.10 (-1.03%)

stock direction

Last updated on: Dec 04, 2024

Market Price of Fredun Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Fredun Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Dec 2024780.1
03 Dec 2024788.2
02 Dec 2024787.75
29 Nov 2024737.2
28 Nov 2024733.9
27 Nov 2024720.9
26 Nov 2024706.85
25 Nov 2024708.25
22 Nov 2024673.7
21 Nov 2024672

SWOT Analysis Of Fredun Pharmaceuticals Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Fredun Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Fredun Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Fredun Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Fredun Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Fredun Pharmaceuticals Ltd

No data available

* All values are in

About Fredun Pharmaceuticals Ltd

  • Incorporated in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was converted into a public limited company in Mar.'94.
  • The Company was promoted by Nariman Medhora and Daulat N Medhora.
  • The promoters initially established D N Pharma, a proprietary firm, for the manufacture and export of pharmaceutical formulations.
  • Since 1993, D N Pharma's operations were phased out in order to switch over the business to FPL. The Company is well diversified in the business ranging from Formulations to Diagnostics to Consultancy.
  • The Company has an unique range of products, from niche formulations , anti-diabetics to the latest antiretroviral and anti - Hypertensive products.

Fredun Pharmaceuticals Ltd News Hub

News

Fredun Pharmaceuticals to discuss results

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 ...

Read more

16 Oct 2024 11:59

News

Fredun Pharmaceuticals to hold board meeting

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 O...

Read more

27 Sep 2024 10:45

News

Fredun Pharmaceuticals to hold AGM

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will...

Read more

19 Sep 2024 17:53

News

Fredun Pharmaceuticals AGM scheduled

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will...

Read more

19 Sep 2024 10:08

News

Fredun Pharmaceuticals schedules board meeting

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 ...

Read more

22 Jul 2024 10:12

News

Board of Fredun Pharmaceuticals recommends final dividend

Fredun Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

08 May 2024 09:31

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Fredun Pharmaceuticals Ltd Market Cap

What is the market cap of Fredun Pharmaceuticals Ltd?

As of December 4, 2024, Fredun Pharmaceuticals Ltd has a market capitalization of ₹366.58, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Fredun Pharmaceuticals Ltd's market capitalization?

Fredun Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Fredun Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Fredun Pharmaceuticals Ltd's market capitalization change?

Fredun Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions